All News

Women who take birth control pills may be protecting themselves against endometrial cancer -- and not just during the years that they use these medications, but in the long term.

Two-time cancer survivor and clutter clearing trainer vents about time management problems with an awareness that her time is her life.

Pneumonitis, a lung inflammation, often appears months after the cancer treatment that sparked it.

The immunotherapy drug Opdivo (nivolumab) prolonged survival in patients with advanced renal cell carcinoma more effectively than a comparator drug, Afinitor (everolimus), in a recent phase 3 study.

Often facing greater disease-related risk, younger women with breast cancer are asked to weigh fertility, sexual health and body image issues within a short window of time – in many cases, without as much guidance as they would like.

The U.S. Food & Drug Administration has approved Odomzo (sonidegib) for the treatment of patients with locally advanced basal cell carcinoma who have experienced a recurrence of this condition after surgery or radiation, or who weren't eligible for those therapies.

I decided to go ahead with my scheduled breast reduction. I'd wait for the genetic testing results, from two weeks to two months. I decided that, for me, breast reduction would still be my choice, even if I had genes that imposed a 50 percent to 80 percent increase in the likelihood of breast cancer. Those of you who read my last post have been waiting with me. I wanted to pose a real-time, real-life conundrum.

Male breast cancer survivor Khevin Barnes tells of an unexpected visitor–and an unforgettable lesson.

An online tool is designed to help men with prostate or other types of cancer deal with sexual dysfunction and other common side effects of treatment.

Oncology experts supported a patient-driven online petition asking Congress to give the government, patients and other stakeholders more power when it comes to negotiating prices for cancer drugs.

Practical tips on how to help a sick friend.

Colorectal cancer is the third leading cause of cancer-related deaths in the United States when men and women are considered separately, and the second leading cause when both sexes are combined.

CURE sat down with Suresh S. Ramalingam to discuss important considerations for patients, caregivers, nurses and physicians when treatment with an immunotherapy begins.

Hirsch Honored With Addario Lectureship Award in Lung Cancer